What is Delta 9 Cannabis Inc. (DN.TO)?

Delta 9 Cannabis Inc. (DN.TO) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

Delta 9 Cannabis Inc. (DN.TO)

Stock analysis · TSX · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.21

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Delta 9 Cannabis Inc. (DN.TO) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Nov 13, 2019

EPS $-0.02 vs est. $-0.06

Beat by $0.04

Proprietary Signals

Signal snapshot temporarily unavailable.

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.